Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Radware
RDWR
$1.1B
| $138K | ﹤0.01% |
5,308
+5,298
| +52,980% | +$145K |
|
3827
KraneShares CSI China Internet ETF
KWEB
$5.64B
| $137K | ﹤0.01% |
1,791
-4,300
| -71% | -$377K |
|
3828
Milestone Scientific
MLSS
$35.3M
| $137K | ﹤0.01% |
38,475
+23,620
| +159% | +$81K |
|
3829
Princeton Bancorp
BPRN
$281M
| $136K | ﹤0.01% |
4,758
+2,922
| +159% | +$75.9K |
|
|
CKPT
3830
DELISTED
Checkpoint Therapeutics
CKPT
| $136K | ﹤0.01% |
4,327
+2,656
| +159% | +$89K |
|
3831
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $136K | ﹤0.01% |
1,600
-3,300
| -67% | -$259K |
|
3832
Compañía de Cervecerías Unidas
CCU
$2.12B
| $135K | ﹤0.01% |
+7,630
| New | +$132K |
|
3833
DHI Group
DHX
$182M
| $135K | ﹤0.01% |
40,129
+24,634
| +159% | +$70.1K |
|
3834
CALL
Nutrien
NTR
$33.2B
| $135K | ﹤0.01% |
2,500
-295,300
| -99% | -$16.1M |
|
3835
Vitamin Cottage Natural Grocers
NGVC
$739M
| $134K | ﹤0.01% |
7,624
+4,680
| +159% | +$73.9K |
|
|
HEWG
3836
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
| $134K | ﹤0.01% |
+4,175
| New | +$127K |
|
|
CSSE
3837
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $134K | ﹤0.01% |
5,535
-79
| -1% | -$2.02K |
|
|
CALA
3838
DELISTED
Calithera Biosciences, Inc
CALA
| $134K | ﹤0.01% |
2,768
+851
| +44% | +$49.5K |
|
|
CASI
3839
DELISTED
CASI Pharmaceuticals
CASI
| $133K | ﹤0.01% |
5,527
+3,393
| +159% | +$95.3K |
|
3840
First Capital
FCAP
$212M
| $133K | ﹤0.01% |
2,722
+1,673
| +159% | +$89.4K |
|
|
ORGS
3841
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $132K | ﹤0.01% |
2,303
+1,275
| +124% | +$83.1K |
|
|
CHMA
3842
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $132K | ﹤0.01% |
42,193
+25,776
| +157% | +$98.9K |
|
3843
Alico
ALCO
$280M
| $131K | ﹤0.01% |
4,359
+2,676
| +159% | +$81.2K |
|
3844
PUT
MPLX
MPLX
$59.3B
| $131K | ﹤0.01% |
5,100
-7,400
| -59% | -$182K |
|
|
AVDL
3845
DELISTED
Avadel Pharmaceuticals
AVDL
| $130K | ﹤0.01% |
14,303
+88
| +0.6% | +$711 |
|
3846
Norwood Financial Corp
NWFL
$370M
| $130K | ﹤0.01% |
4,863
+2,986
| +159% | +$77.8K |
|
3847
Peoples Bancorp of North Carolina
PEBK
$229M
| $130K | ﹤0.01% |
5,525
+2,293
| +71% | +$54.6K |
|
3848
Capital Bancorp
CBNK
$608M
| $129K | ﹤0.01% |
6,643
+4,078
| +159% | +$66.8K |
|
3849
C&F Financial
CFFI
$268M
| $129K | ﹤0.01% |
2,902
+1,783
| +159% | +$76.6K |
|
3850
Dyadic International
DYAI
$38.3M
| $129K | ﹤0.01% |
23,669
+9,896
| +72% | +$54.9K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.